Dental Anesthesia Market 2018 by Shares Analysis, Key Development Strategies and Forecasts Till 2023 | Avail at

“Dental Anesthesia Market”
Market Research Future published a research report on Global Dental Anesthesia Market to provide detailed analysis of the market structure along with forecast for the next 5 years of the various segments and sub-segments of the Dental Anesthesia Market and upcoming challenges and opportunity in Market till 2023.

The Global Dental Anesthesia Market is growing exponentially owing to the increasing dental healthcare base, increasing trend towards dental health checkup, growing economy are the factor contributing to the growth of the market. The Dental Anesthesia Market is expected to register a CAGR of about 8.9% over the forecast period (2017-2023).

Anesthesias are drugs that has the ability to induce reversible sensation loss. Local anesthesia (vasoconstrictors) are different from analgesic or pain killers which relives pain without loss of sensation. They are usually administered to facilitate surgery. In U.S., the two vasoconstrictors are levonordefrin and epinephrine. Epinephrine used for dental Anesthesias include lidocaine, articaine, prilocaine, and bupivacaine. Dental Anesthesia consists of both local Anesthesia and general Anesthesia. These Anesthesias are used in nonsurgical periodontal therapy (NSPT) procedures.

The Global Dental Anesthesia Market for diagnosis and treatment is expected to grow at a CAGR of approximately 8.9% during the forecast period 2017–2023.

Get PDF Sample Copy of Report @ .

Key Players of Dental Anesthesia Market

Some major players in the Global Dental Anesthesia Market include Astra Zeneca (UK), Septodont (US), Dentsply (US), Sirona (US), GlaxoSmithKline PLC (US), Gilead Sciences Inc. (US), Johnson & Johnson (US), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter International Inc. (US), Abbott Laboratories (US), Hospira, Inc. (US), Hikma Pharmaceuticals PLC (UK), AbbVie Inc. (US), Fresenius Se & Co. Kgaa (Germany), and others.

Industry Updates of Dental Anesthesia Market

September, 2017 AstraZeneca entered into a collaboration agreement with Aspen Global Incorporated (AGI) to acquire the rights for anaesthetic medicine outside U.S. The anaesthetic medication portfolio include EMLA, Xyloproct /Xylocard/ Xylocaine, Diprivan, Marcaine, Naropin, Citanest and Carbocaine. The agreement will imply AstraZeneca to manufacture and supply medication to AGI over a period of 5 years.

Feb, 2017 Septodont Healthcare India Pvt. Ltd. acquires DLA, a leading injectable dental Anesthesias manufactures. The leading dental Anesthesias includes Lidostesim (Lidocaine), Mepivalem (Mepivacaine) and Citanest (Priolocaine). This acquisition will strengthen their presence throughout the Latin American region.

March, 2017 GlaxoSmithKline plc divested nearly all their Anesthesias portfolio to Aspen Pharma. By this acquisition Aspen has strengthened its drug portfolio and increased its customer base. GSK’s anaesthesia portfolio consists of Anectine, Ultiva, Mivacron Tracrium, and Nimbex. In addition, Aspen and GSK has entered into parallel agreements to terminate their collaboration in Africa and further exercise an option to acquire GSK’s remaining thrombosis business.        

July, 2016 Kitron signs supply agreement with Dentsply Sirona. This agreement will add Kitron as a new supplier for Dentsply Sirona.

Get an Attractive Discount on Report @ .

Key Questions Answered In This Report:

What will the market size and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Some Brief Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

TOC Continued…


Table 1 Dental Anesthesia Industry Synopsis, 2017–2023

Table 2 Dental Anesthesia Market Estimates & Forecast, 2017–2023, (USD Million)

Table 3 Dental Anesthesia Market, By Region, 2017–2023, (USD Million)

Table 4 Dental Anesthesia Market, By Species, 2017–2023, (USD Million)

Table 5 Dental Anesthesia Market, By Types Of Anesthesia, 2017–2023, (USD Million)

Table 6 Dental Anesthesia Market, By Mode Of Administration, 2017–2023, (USD Million)

Table 7 Dental Anesthesia Market, By End-User, 2017–2023, (USD Million)

Table 8 North America Dental Anesthesia Market, By Species, 2017–2023, (USD Million)



Figure 1 Research Process

Figure 2 Segmentation For Dental Anesthesia Market

Figure 3 Segmentation Market Dynamics For Dental Anesthesia Market

Figure 4 Global Dental Anesthesia Market Share, By Species 2016

Figure 6 Global Dental Anesthesia Market Share, By Types Of Anesthesia 2016

Figure 7 Global Dental Anesthesia Market Share, By Mode Of Administration, 2016

Figure 8 Global Dental Anesthesia Market Share, By End-User, 2016

Figure 9 Global Dental Anesthesia Market Share, By Region, 2016


Do You Have any Specific Requirement? Inquire @ .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312


Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India